Group One Trading
NMRA icon

Group One Trading’s Neumora Therapeutics NMRA Stock Holding History

Group One Trading’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4K Buy
+7,900
New +$20.5K ﹤0.01% 6114
2025
Q4 		– Sell
-28,300
Closed -$51.5K – 8824
2025
Q3 		$51.5K Buy
28,300
+19,800
+233% +$32K ﹤0.01% 5938
2025
Q2 		$6.23K Sell
8,500
-18,700
-69% -$14.2K ﹤0.01% 6990
2025
Q1 		$27.2K Sell
27,200
-10,400
-28% -$17.8K ﹤0.01% 5607
2024
Q4 		$399K Buy
37,600
+37,200
+9,300% +$446K ﹤0.01% 3362
2024
Q3 		$5.28K Buy
+400
New +$4.67K ﹤0.01% 5857

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return